|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0008976,
umls-concept:C0023981,
umls-concept:C0030705,
umls-concept:C0032207,
umls-concept:C0079083,
umls-concept:C0680218,
umls-concept:C0684249,
umls-concept:C1521750,
umls-concept:C1707455,
umls-concept:C1707491
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2001-7-2
|
|
pubmed:abstractText |
A prospective randomized trial in small-cell lung cancer (SCLC) was performed to determine if intensification of the platinum dose by giving cisplatin and carboplatin in combination to patients with SCLC yields higher response rates and survival, than carboplatin alone in a combination chemotherapy regimen.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
647-53
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11432623-Adult,
pubmed-meshheading:11432623-Aged,
pubmed-meshheading:11432623-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11432623-Carboplatin,
pubmed-meshheading:11432623-Carcinoma, Small Cell,
pubmed-meshheading:11432623-Cisplatin,
pubmed-meshheading:11432623-Cyclophosphamide,
pubmed-meshheading:11432623-Dose-Response Relationship, Drug,
pubmed-meshheading:11432623-Epirubicin,
pubmed-meshheading:11432623-Female,
pubmed-meshheading:11432623-Humans,
pubmed-meshheading:11432623-Infusions, Intravenous,
pubmed-meshheading:11432623-Lung Neoplasms,
pubmed-meshheading:11432623-Male,
pubmed-meshheading:11432623-Mesna,
pubmed-meshheading:11432623-Middle Aged,
pubmed-meshheading:11432623-Prospective Studies,
pubmed-meshheading:11432623-Survival Analysis,
pubmed-meshheading:11432623-Teniposide,
pubmed-meshheading:11432623-Treatment Outcome,
pubmed-meshheading:11432623-Vincristine
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patients.
|
|
pubmed:affiliation |
Rigshospitalet, Finsen Center, Department of Oncology, Denmark. Fred.Hirsch@UCHSC.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|
